Olon USA will exhibit at the 24th Annual Contract Pharma Conference in New Brunswick, New Jersey, on September 18–19, 2025. Visitors can meet the team at table 144. The conference is a key gathering for contract development and manufacturing organizations (CDMOs), pharmaceutical companies, and biopharmaceutical innovators. For the first time, Olon USA will showcase its capabilities as part of the Olon Group, a global leader in active pharmaceutical ingredient (API) development and manufacturing. This event provides an important opportunity for companies to learn how Olon USA can support complex projects with U.S.-based operations backed by a worldwide network.
A Strategic Event for Pharmaceutical Partnerships
The Contract Pharma Conference is designed for pharmaceutical and biopharmaceutical professionals focused on outsourcing, development, and supply chain strategy. Its location in the New Jersey, New York, and Pennsylvania corridor makes it accessible to many small and mid-sized pharma companies, as well as global organizations with U.S. operations. For companies seeking reliable CDMO partners, the conference provides a direct way to explore new collaborations.
Addressing Industry Pressures
API development and manufacturing programs are facing new challenges, including tariff uncertainties, supply chain disruption, and evolving regulatory requirements. These issues can create delays and risks for projects dependent on global sourcing. Olon USA’s team will be available at the conference to discuss how its global procurement resources across the United States, Europe, India, and China allow customers to navigate these market dynamics while securing reliable supply and managing cost exposure.
U.S. and Global Capabilities
Olon USA delivers API development and manufacturing capabilities within the United States while providing seamless access to the wider Olon Group network of facilities across Europe and Asia. This integrated model gives customers the flexibility to pursue domestic programs, leverage global scale, or combine both strategies depending on project needs.
Direct Access to Scientists
Olon USA emphasizes scientific collaboration without unnecessary barriers. Customers work directly with development scientists and technical experts, ensuring clear communication, rapid feedback, and informed decision-making throughout each stage of the project. This approach helps maintain program timelines and reduces the risk of misalignment that can occur with layered communication structures.
Opportunities in U.S. Manufacturing
Olon USA is expanding its U.S. facility with new capacity and equipment to support larger-scale commercial manufacturing. In addition, the team is exploring collaborative partnership models that allow customers to establish operations within Olon’s site, supported by experienced staff and infrastructure. These investments strengthen the ability to meet increasing demand for domestic API manufacturing capacity while maintaining alignment with global quality and compliance standards.
Meet the Team at Table 144
Olon USA welcomes attendees to visit table 144 during the Contract Pharma Conference to discuss CDMO services, API development strategies, and pharmaceutical manufacturing solutions. The event provides a streamlined setting for meaningful conversations about current challenges and opportunities in drug development.
Start the Conversation
Companies looking for a CDMO partner with strong U.S. operations and global reach are encouraged to connect with Olon USA at the conference or reach out directly to initiate discussions. Contact Olon USA to explore how its expertise in API development and pharmaceutical manufacturing can support the success of your next project.